Buyuk, M. Et Al. 2023. Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS). TURKISH JOURNAL OF PATHOLOGY , vol.39, no.1 , 64-74.

Buyuk, M., Ozluk, Y., Bakkaloglu, D., Ozkan, B., Firat, P., & Yilmazbayhan, D., (2023). Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS). TURKISH JOURNAL OF PATHOLOGY , vol.39, no.1, 64-74.

Buyuk, Melek Et Al. "Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)," TURKISH JOURNAL OF PATHOLOGY , vol.39, no.1, 64-74, 2023

Buyuk, Melek Et Al. "Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)." TURKISH JOURNAL OF PATHOLOGY , vol.39, no.1, pp.64-74, 2023

Buyuk, M. Et Al. (2023) . "Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)." TURKISH JOURNAL OF PATHOLOGY , vol.39, no.1, pp.64-74.

@article{article, author={Melek BÜYÜK Et Al. }, title={Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)}, journal={TURKISH JOURNAL OF PATHOLOGY}, year=2023, pages={64-74} }